vs
Side-by-side financial comparison of Commercial Bancgroup, Inc. (CBK) and IRIDEX CORP (IRIX). Click either name above to swap in a different company.
Commercial Bancgroup, Inc. is the larger business by last-quarter revenue ($23.1M vs $14.7M, roughly 1.6× IRIDEX CORP).
Commercial Bancgroup, Inc.CBKEarnings & Financial Report
Commercial Bancgroup, Inc. operates as a U.S. regional bank holding company that provides a full suite of retail and commercial banking products and services to individual consumers, small and medium-sized businesses, and local institutional clients. Its core offerings include deposit accounts, lending solutions, wealth management, and tailored financial advisory services for regional markets.
IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.
CBK vs IRIX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.1M | $14.7M |
| Net Profit | $9.5M | — |
| Gross Margin | — | 37.2% |
| Operating Margin | — | — |
| Net Margin | 41.3% | — |
| Revenue YoY | — | -69.7% |
| Net Profit YoY | 9.7% | — |
| EPS (diluted) | $0.69 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $23.1M | — | ||
| Q4 25 | $23.5M | $14.7M | ||
| Q3 25 | $22.8M | $12.5M | ||
| Q2 25 | — | $13.6M | ||
| Q1 25 | — | $11.9M | ||
| Q4 24 | — | $12.7M | ||
| Q3 24 | — | $11.6M | ||
| Q2 24 | — | $12.6M |
| Q1 26 | $9.5M | — | ||
| Q4 25 | $9.9M | — | ||
| Q3 25 | $9.5M | $-1.6M | ||
| Q2 25 | — | $-994.0K | ||
| Q1 25 | — | $-1.7M | ||
| Q4 24 | — | $-834.0K | ||
| Q3 24 | — | $-1.9M | ||
| Q2 24 | — | $-2.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | 37.2% | ||
| Q3 25 | — | 32.1% | ||
| Q2 25 | — | 34.5% | ||
| Q1 25 | — | 42.5% | ||
| Q4 24 | — | 44.0% | ||
| Q3 24 | — | 37.3% | ||
| Q2 24 | — | 40.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 53.8% | -11.3% | ||
| Q2 25 | — | -6.9% | ||
| Q1 25 | — | -1.7% | ||
| Q4 24 | — | -3.9% | ||
| Q3 24 | — | -16.1% | ||
| Q2 24 | — | -20.9% |
| Q1 26 | 41.3% | — | ||
| Q4 25 | 42.2% | — | ||
| Q3 25 | 41.4% | -12.6% | ||
| Q2 25 | — | -7.3% | ||
| Q1 25 | — | -14.2% | ||
| Q4 24 | — | -6.6% | ||
| Q3 24 | — | -16.7% | ||
| Q2 24 | — | -21.2% |
| Q1 26 | $0.69 | — | ||
| Q4 25 | $0.72 | — | ||
| Q3 25 | $0.77 | $-0.09 | ||
| Q2 25 | — | $-0.06 | ||
| Q1 25 | — | $-0.10 | ||
| Q4 24 | — | $-0.05 | ||
| Q3 24 | — | $-0.12 | ||
| Q2 24 | — | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $6.0M |
| Total DebtLower is stronger | $118.2M | — |
| Stockholders' EquityBook value | — | — |
| Total Assets | $2.3B | $29.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $6.0M | ||
| Q3 25 | $154.8M | $5.6M | ||
| Q2 25 | — | $6.8M | ||
| Q1 25 | — | $7.2M | ||
| Q4 24 | — | $2.4M | ||
| Q3 24 | — | $3.9M | ||
| Q2 24 | — | $4.1M |
| Q1 26 | $118.2M | — | ||
| Q4 25 | $166.8M | — | ||
| Q3 25 | $100.1M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.0M | ||
| Q3 24 | — | $1.4M | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $245.2M | $4.7M | ||
| Q2 25 | — | $6.1M | ||
| Q1 25 | — | $852.0K | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | — | $2.6M | ||
| Q2 24 | — | $4.2M |
| Q1 26 | $2.3B | — | ||
| Q4 25 | $2.3B | $29.2M | ||
| Q3 25 | $2.2B | $28.4M | ||
| Q2 25 | — | $31.6M | ||
| Q1 25 | — | $34.2M | ||
| Q4 24 | — | $29.1M | ||
| Q3 24 | — | $30.2M | ||
| Q2 24 | — | $31.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.41× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.48× | ||
| Q3 24 | — | 0.53× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBK
| Net Interest Income | $20.5M | 89% |
| Noninterest Income | $2.6M | 11% |
IRIX
Segment breakdown not available.
